Skip to main content

Table 6 Effect of treatment at first 15 weeks comparing sulforaphane (SF) and placebo (PL) groups

From: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

Biomarker SF (exposure) PL (non-exposure)
N F-statistic p value N F-statistic p value
Free reduced GSHa 22 1.51 0.232 23 0.11 0.746
Total GSHa 22 0.00 0.945 23 0.08 0.776
GSSGa 22 1.97 0.175 23 0.46 0.505
Free GSH:GSSG 22 12.72 0.002 23 0.87 0.361
Total GSH:GSSG 22 5.16 0.034 23 0.03 0.875
  1. Bold signifies p < 0.05
  2. MANOVA test used for repeated measures (compared to baseline at 0 weeks)
  3. aNatural log transformed